Telaprevir

spinqualitylabelsall models Crystal structure of NS3/4A protease in complex with Telaprevir (3sv6) Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Telaprevir (VX-950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3/4A serine protease. See also [1]. Crystal structure of NS3/4A protease in complex with Telaprevir (3sv6). Telaprevir binding site.

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky